Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1991 2
1992 2
1993 2
1994 3
1995 6
1996 4
1997 7
1998 5
1999 8
2000 7
2001 6
2002 2
2003 8
2004 7
2005 4
2006 3
2007 7
2008 11
2009 9
2010 11
2011 11
2012 10
2013 16
2014 6
2015 3
2016 9
2017 9
2018 8
2019 7
2020 8
2021 11
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

198 results
Results by year
Filters applied: . Clear all
Page 1
Subcellular Distribution of p53 by the p53-Responsive lncRNA NBAT1 Determines Chemotherapeutic Response in Neuroblastoma.
Mitra S, Muralidharan SV, Di Marco M, Juvvuna PK, Kosalai ST, Reischl S, Jachimowicz D, Subhash S, Raimondi I, Kurian L, Huarte M, Kogner P, Fischer M, Johnsen JI, Mondal T, Kanduri C. Mitra S, et al. Among authors: kogner p. Cancer Res. 2021 Mar 15;81(6):1457-1471. doi: 10.1158/0008-5472.CAN-19-3499. Epub 2020 Dec 28. Cancer Res. 2021. PMID: 33372039
NSAIDs in neuroblastoma therapy.
Johnsen JI, Lindskog M, Ponthan F, Pettersen I, Elfman L, Orrego A, Sveinbjörnsson B, Kogner P. Johnsen JI, et al. Among authors: kogner p. Cancer Lett. 2005 Oct 18;228(1-2):195-201. doi: 10.1016/j.canlet.2005.01.058. Cancer Lett. 2005. PMID: 15975708 Review.
Targeting the COX/mPGES-1/PGE2 Pathway in Neuroblastoma.
Larsson K, Kock A, Kogner P, Jakobsson PJ. Larsson K, et al. Among authors: kogner p. Adv Exp Med Biol. 2019;1161:89-100. doi: 10.1007/978-3-030-21735-8_9. Adv Exp Med Biol. 2019. PMID: 31562624
Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial.
Ladenstein R, Pötschger U, Pearson ADJ, Brock P, Luksch R, Castel V, Yaniv I, Papadakis V, Laureys G, Malis J, Balwierz W, Ruud E, Kogner P, Schroeder H, de Lacerda AF, Beck-Popovic M, Bician P, Garami M, Trahair T, Canete A, Ambros PF, Holmes K, Gaze M, Schreier G, Garaventa A, Vassal G, Michon J, Valteau-Couanet D; SIOP Europe Neuroblastoma Group (SIOPEN). Ladenstein R, et al. Among authors: kogner p. Lancet Oncol. 2017 Apr;18(4):500-514. doi: 10.1016/S1470-2045(17)30070-0. Epub 2017 Mar 2. Lancet Oncol. 2017. PMID: 28259608 Clinical Trial.
Embryonal neural tumours and cell death.
Johnsen JI, Kogner P, Albihn A, Henriksson MA. Johnsen JI, et al. Among authors: kogner p. Apoptosis. 2009 Apr;14(4):424-38. doi: 10.1007/s10495-009-0325-y. Apoptosis. 2009. PMID: 19259824 Free article. Review.
Integrative discovery of treatments for high-risk neuroblastoma.
Almstedt E, Elgendy R, Hekmati N, Rosén E, Wärn C, Olsen TK, Dyberg C, Doroszko M, Larsson I, Sundström A, Arsenian Henriksson M, Påhlman S, Bexell D, Vanlandewijck M, Kogner P, Jörnsten R, Krona C, Nelander S. Almstedt E, et al. Among authors: kogner p. Nat Commun. 2020 Jan 3;11(1):71. doi: 10.1038/s41467-019-13817-8. Nat Commun. 2020. PMID: 31900415 Free PMC article.
Galanin and galanin receptors in human cancers.
Berger A, Santic R, Hauser-Kronberger C, Schilling FH, Kogner P, Ratschek M, Gamper A, Jones N, Sperl W, Kofler B. Berger A, et al. Among authors: kogner p. Neuropeptides. 2005 Jun;39(3):353-9. doi: 10.1016/j.npep.2004.12.016. Epub 2005 Jan 28. Neuropeptides. 2005. PMID: 15944034 Review.
198 results